Rua Bioscience (NZSE:RUA) Beginning Cash Position: NZ$2.17 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Rua Bioscience Beginning Cash Position?

Rua Bioscience NZSE:RUA -5.88% Beginning Cash Position is NZ$2.17 Mil as of Jun. 2026. The stock has 8 warning signs investors should review.

Rua Bioscience's Beginning Cash Position for the quarter that ended in Jun. 2026 was NZ$2.17 Mil.

Rua Bioscience's quarterly Beginning Cash Position declined from Jun. 2025 (NZ$0.54 Mil) to Dec. 2025 (NZ$0.24 Mil) but then increased from Dec. 2025 (NZ$0.24 Mil) to Jun. 2026 (NZ$2.17 Mil).

Rua Bioscience's annual Beginning Cash Position declined from Jun. 2024 (NZ$2.53 Mil) to Jun. 2025 (NZ$0.90 Mil) and declined from Jun. 2025 (NZ$0.90 Mil) to Jun. 2026 (NZ$0.24 Mil).

Rua Bioscience Beginning Cash Position Related Terms

Rua Bioscience Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Rua Bioscience's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rua Bioscience Beginning Cash Position Chart

Rua Bioscience Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25 Jun26
Beginning Cash Position
Get a 7-Day Free Trial 3.36 1.90 2.53 0.90 0.24

Rua Bioscience Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.97 0.90 0.54 0.24 2.17

Rua Bioscience Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of NZ$2.17 Mil mean?
Rua Bioscience (NZSE:RUA) has a Beginning Cash Position of NZ$2.17 Mil as of Jun. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Rua Bioscience and its competitors.
Is Rua Bioscience's Beginning Cash Position too high?
Rua Bioscience's current Beginning Cash Position is NZ$2.17 Mil.
How does Rua Bioscience's Beginning Cash Position compare to ZTS and UTHR?
Rua Bioscience's Beginning Cash Position of NZ$2.17 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Drug Manufacturers company?
A good Beginning Cash Position depends on the Drug Manufacturers industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Rua Bioscience and its competitors. Rua Bioscience's current Beginning Cash Position is NZ$2.17 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rua Bioscience stock overvalued right now?
Based on GuruFocus' analysis, Rua Bioscience (NZSE:RUA) is currently considered Possible Value Trap. The stock's GF Value™ is NZ$0.10, compared to a current price of NZ$0.03 — trading 68% below its estimated fair value. The current Beginning Cash Position is NZ$2.17 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Rua Bioscience (NZSE:RUA), the current Beginning Cash Position is NZ$2.17 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Rua Bioscience Business Description

Address 704 Te Araroa Road, RD3, Ruatoria, NZL, 4083
Rua Bioscience Ltd is a pharmaceutical company engaged in the production of cannabinoid medicines. The company caters to both domestic and international customers. It operates in one segment, being research and development and the sale of pharmaceutical products in Australia, Germany, and New Zealand.